Glaucomatous Optic Disc & Visual Field Changes

Glaucoma is a progressive optic neuropathy characterised by accelerated loss of retinal ganglion cells and their axons, producing structural optic disc cupping that correlates with functional visual-field defects. Mastering this structure–function correlation is the single highest-yield clinical skill in glaucoma — it underlies almost every NEET PG image-based and scenario question on the topic.

Definition & Core Concept

Glaucoma is not simply "high intraocular pressure (IOP)". It is defined as a characteristic optic neuropathy with corresponding visual-field loss, in which raised IOP is the chief modifiable risk factor (but neither necessary nor sufficient). The disease attacks the retinal nerve fibre layer (RNFL) and the neuroretinal rim of the optic nerve head.

The optic disc has ~1.2 million axons converging into the cup-and-rim architecture. Loss of axons → thinning of the neuroretinal rim → enlargement of the optic cup → cupping. Because axons are arranged in an anatomically predictable pattern, specific patterns of axonal loss produce specific, recognisable field defects.

High-yield: Structural disc damage precedes detectable field loss on standard automated perimetry (SAP). Up to 40–50% of ganglion cells may be lost before a reproducible field defect appears — hence OCT/RNFL imaging detects "pre-perimetric glaucoma".

The Normal Optic Disc — Baseline for Comparison

Parameter	Normal value / feature
Disc diameter (vertical)	~1.5 mm
Cup-to-disc ratio (CDR)	≤ 0.3 in most eyes
Rim configuration	Follows the ISNT rule
Rim colour	Healthy pink/orange (good perfusion)
Disc symmetry between eyes	CDR asymmetry < 0.2

ISNT rule — the neuroretinal rim is thickest Inferior > Superior > Nasal > Temporal. Violation of the ISNT rule is an early, sensitive sign of glaucomatous damage.

High-yield: A CDR asymmetry > 0.2 between the two eyes is highly suspicious for glaucoma, because physiological cups are usually symmetrical. This is a favourite single-line MCQ.

Glaucomatous Optic Disc Changes (Structural)

These are the disc signs you must be able to recognise and name:

1. Generalised enlargement of the cup — concentric loss; CDR increases overall.
2. Vertical (vertically oval) elongation of the cup — because rim loss preferentially affects the superior and inferior poles first (the most vulnerable axons), the cup elongates vertically. Vertical CDR > horizontal CDR is characteristic.
3. Focal notching of the rim — a localised excavation, most often at the inferotemporal or superotemporal rim. A notch produces a corresponding arcuate field defect.
4. ISNT rule violation — earliest sign; the inferior rim thins first, so inferior is no longer the thickest.
5. Splinter (Drance) haemorrhage — flame-shaped haemorrhage crossing the disc margin, usually inferotemporal. Marks a site of active, progressing damage and predicts future field loss.
6. Bayoneting sign — vessels bend sharply at the cup edge then run along the steep wall, resembling a bayonet, due to undermining/overhanging of the cup wall.
7. Baring of circumlinear vessels — a vessel that previously hugged the rim now has a gap between it and the rim margin due to rim loss.
8. Nasalisation of vessels — bowing of the central retinal vessels nasally as the cup enlarges.
9. Laminar dot sign — increased visibility of grey pores of the lamina cribrosa at the cup base.
10. Peripapillary atrophy (PPA) — especially the beta-zone (bare sclera/choroid), enlarges with progression.
11. Acquired pit of the optic nerve — focal, deep rim defect; strongly linked to dense localised field loss.
12. Saucerisation / shallow generalised cupping — characteristic of normal-tension glaucoma (NTG) and myopic discs.

High-yield: Vertical cup enlargement + ISNT violation + inferotemporal notch + Drance haemorrhage is the classic combination tested in NEET image questions. Drance haemorrhage is especially associated with normal-tension glaucoma.

Pathophysiology of cupping (flow): Raised IOP and/or vascular dysregulation → mechanical & ischaemic stress at the lamina cribrosa → posterior bowing of lamina → blockade of axoplasmic transport in ganglion cell axons → axonal apoptosis → loss of neuroretinal rim tissue → cup enlargement & RNFL thinning → arcuate / nasal field defects → progression to tunnel vision.

The Retinal Nerve Fibre Layer (RNFL) — Why Defects Occur Where They Do

Ganglion cell axons enter the disc in a specific arrangement that dictates field-defect topography:

• Papillomacular bundle — enters the temporal disc; serves central vision (resistant; lost late).
• Arcuate (arching) fibres — from the temporal retina, they arch above and below the macula and respect the horizontal raphe (a horizontal dividing line temporal to the macula). They enter the superior and inferior poles — the most vulnerable region.
• Radial nasal fibres — enter the nasal disc directly.

Because arcuate fibres respect the horizontal raphe, glaucomatous defects characteristically respect the horizontal midline and form arc-shaped scotomas.

High-yield: Glaucomatous field defects respect the horizontal meridian (not the vertical). Defects respecting the vertical meridian point instead to a chiasmal/retrochiasmal (neurological) lesion — a classic distinguishing MCQ.

Glaucomatous Visual Field Changes (Functional)

Standard automated perimetry (SAP), e.g. Humphrey 24-2 or 30-2, is the reference test. Field defects evolve in a predictable sequence:

Sequence of perimetric loss (flow):

1. Isolated paracentral scotoma (within 10–20° of fixation, Bjerrum area) →
2. Nasal step of Rönne (a step-like defect at the nasal horizontal meridian; earliest reproducible change) →
3. Arcuate (Bjerrum) scotoma — arcing from the blind spot around fixation toward the nasal raphe →
4. Seidel scotoma — arcuate scotoma still connected to the blind spot →
5. Double arcuate / ring scotoma — superior + inferior arcuate defects join →
6. Peripheral nasal & temporal constriction, with sparing of central and a temporal island →
7. Tubular (tunnel) vision and a residual temporal crescent →
8. End-stage: loss of the temporal island → total blindness.

Field defect	Location / feature	Significance
Baring of the blind spot	Enlargement of physiological blind spot	Non-specific, early
Paracentral scotoma	Bjerrum area, 10–20°	One of the earliest
Nasal step (Rönne)	Step at nasal horizontal raphe	Earliest reproducible defect
Bjerrum / arcuate scotoma	Arching 10–20° around fixation	Hallmark of established glaucoma
Seidel scotoma	Arcuate, still joined to blind spot	Intermediate
Ring (double arcuate) scotoma	Superior + inferior arcuate merge	Advanced
Tubular vision + temporal island	Central + far temporal sparing	End-stage

High-yield: Central (macular) vision and a temporal island are preserved until the very end in glaucoma. This is why patients retain 6/6 acuity despite gross field loss and present late — a heavily tested clinical pearl.

Structure–Function Correlation (The Examiner's Favourite)

The disc and field damage map onto each other anatomically. Because the optical image is inverted, superior disc damage → inferior field defect, and vice versa:

Disc / RNFL finding	Corresponding field defect
Inferotemporal rim notch / RNFL wedge	Superior arcuate scotoma / superior nasal step
Superotemporal rim notch / RNFL wedge	Inferior arcuate scotoma / inferior nasal step
Generalised concentric cupping	Generalised depression / diffuse loss
Acquired optic pit	Dense localised arcuate defect

Because the inferotemporal rim is damaged earliest (ISNT — inferior thins first), the superior visual field is affected first, and patients may notice a superior/superonasal field defect.

High-yield: Mnemonic for the inversion — "Damage is upside-down": an inferior disc notch causes a superior field defect. This single rule answers most structure–function MCQs.

Investigations — Documenting and Monitoring Damage

• Optic disc evaluation — slit-lamp biomicroscopy with +78D/+90D lens; stereo disc photographs for documentation.
• Optical Coherence Tomography (OCT) — investigation of choice for objective, quantitative RNFL thickness, ganglion cell complex (GCC), and rim/cup analysis; detects pre-perimetric damage. Look for the "double-hump" RNFL pattern with thinning superiorly/inferiorly.
• Standard Automated Perimetry (SAP) — gold standard for functional assessment and progression; uses Glaucoma Hemifield Test, Pattern Standard Deviation (PSD) and Mean Deviation (MD). The Anderson–Hodapp–Parrish criteria grade severity (mild MD > −6 dB, moderate −6 to −12 dB, severe < −12 dB).
• Frequency Doubling Technology (FDT) & SWAP (blue-on-yellow) — detect early functional loss before SAP.
• Tonometry (Goldmann applanation = gold standard), gonioscopy (angle status), pachymetry (central corneal thickness — thin cornea underestimates IOP and is an independent risk factor — OHTS).

High-yield: OCT is the investigation of choice for structural (pre-perimetric) detection; perimetry (SAP) remains the gold standard for functional diagnosis and monitoring progression. Know both roles.

Clinical Features

Primary open-angle glaucoma (the prototype) is insidious and asymptomatic until advanced — "the silent thief of sight". Patients retain central acuity, so they present late with constricted fields, difficulty in dim light, or are detected on routine screening. In contrast, angle-closure presents acutely with pain, haloes, redness and a mid-dilated fixed pupil. The disc/field signs discussed apply to chronic glaucomas of all types once the optic neuropathy is established.

Management — Lowering IOP (the only proven intervention)

The goal is to lower IOP to a target that halts progression of disc/field damage. Lowering IOP is the only evidence-based treatment, validated for POAG and even normal-tension glaucoma (CNTGS showed 30% IOP reduction slows progression).

Stepwise approach: Medical therapy → Laser → Surgery.

• First-line drug of choice: Prostaglandin analogues (latanoprost, travoprost, bimatoprost) — once-daily, most potent IOP reduction (increase uveoscleral outflow). Side effects: iris/peri-orbital hyperpigmentation, eyelash growth, conjunctival hyperaemia.
• Beta-blockers (timolol) — reduce aqueous production; avoid in asthma/COPD/heart block.
• Alpha-2 agonists (brimonidine), topical/oral carbonic anhydrase inhibitors (dorzolamide, brinzolamide, acetazolamide), Rho-kinase inhibitors (netarsudil), pilocarpine.
• Laser: Selective Laser Trabeculoplasty (SLT) — increasingly used as first-line (LiGHT trial).
• Surgery: Trabeculectomy (gold-standard filtering surgery), drainage implants, MIGS.

High-yield: Prostaglandin analogues are the first-line medical therapy for POAG (best efficacy, once daily, fewest systemic effects). Trabeculectomy is the standard surgical procedure.

Differentials — Glaucomatous vs Non-Glaucomatous Cupping/Field Loss

Distinguishing glaucoma from neurological causes is a recurring NEET theme:

Feature	Glaucomatous optic neuropathy	Non-glaucomatous (e.g. compressive/ischaemic)
Disc appearance	Cupping (rim loss, deep cup)	Pallor > cupping (rim pale but preserved)
Field defect axis	Respects horizontal meridian	Often respects vertical meridian (chiasmal)
Central acuity	Preserved till late	Often reduced early
Colour vision	Preserved till late	Affected early (esp. optic neuritis)
RAPD	Late/asymmetric	Often present early

High-yield: Pallor out of proportion to cupping = suspect a non-glaucomatous (compressive) optic neuropathy → image the brain/orbit (MRI). Cupping out of proportion to pallor = glaucoma.

Other causes of large/suspicious cups: physiological large cup (large disc, ISNT respected, symmetric), myopic disc, optic disc coloboma/pit, congenital/megalopapilla.

Complications

• Irreversible blindness — glaucoma is the leading cause of irreversible blindness worldwide (cataract is leading reversible cause).
• Progressive field constriction → loss of mobility, driving and independence.
• "Wipe-out" / snuff-out phenomenon — sudden loss of remaining central island after surgery in end-stage discs.
• Disc haemorrhage signalling ongoing progression despite "controlled" IOP.

Recently asked / exam angle

• Earliest reproducible field defect in glaucoma? → Nasal step (of Rönne) / paracentral scotoma in Bjerrum's area.
• Last to be lost in glaucoma? → Central (macular) vision and the temporal island.
• Inferotemporal notch on disc → which field defect? → Superior arcuate scotoma (image inversion).
• Which sign signals active progression / is linked to NTG? → Drance (splinter) disc haemorrhage.
• ISNT rule / which rim thins first? → Inferior rim thins first.
• Investigation of choice for early (pre-perimetric) detection? → OCT RNFL.
• Field defect respecting vertical meridian → think chiasm, not glaucoma.
• First-line drug for POAG → prostaglandin analogue (latanoprost).
• Leading cause of irreversible blindness → glaucoma.
• Bayoneting / baring of circumlinear vessel / laminar dot sign — name-the-sign image questions.

Rapid revision

1. Glaucoma = optic neuropathy + field loss; raised IOP is the chief modifiable risk factor, not the definition.
2. Neuroretinal rim follows ISNT (Inferior > Superior > Nasal > Temporal); inferior thins first.
3. CDR asymmetry > 0.2 between eyes is suspicious; vertical cup enlargement is characteristic.
4. Drance (splinter) haemorrhage = active progression; classically linked to normal-tension glaucoma.
5. Structure–function is inverted: inferior disc notch → superior field defect.
6. Earliest reproducible field defect = nasal step of Rönne; hallmark = Bjerrum (arcuate) scotoma.
7. Glaucomatous fields respect the horizontal meridian; vertical-respecting defects = neurological.
8. Central vision and temporal island preserved till end → late presentation, normal acuity despite gross loss.
9. OCT RNFL detects pre-perimetric (structural) damage; SAP perimetry is the functional gold standard.
10. Anderson–Hodapp criteria grade field severity by MD; Goldmann applanation = IOP gold standard.
11. Pallor > cupping → suspect compressive/ischaemic optic neuropathy; image with MRI.
12. First-line drug = prostaglandin analogue; standard surgery = trabeculectomy; SLT is rising as first-line laser.